Corpus Intelligence IC Memo — WILLAMETTE VALLEY MEDICAL CENTER 2026-04-26 08:09 UTC
IC Memo — WILLAMETTE VALLEY MEDICAL CENTER
Investment Committee Memorandum | OR | 50 beds | Grade C | EBITDA uplift $8.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

WILLAMETTE VALLEY MEDICAL CENTER

CCN 380071 | nan, OR | 50 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

WILLAMETTE VALLEY MEDICAL CENTER is a 50-bed suburban community hospital in nan, OR with $110.4M in net patient revenue and a -6.1% operating margin. The hospital serves a payer mix of 29.0% Medicare, 3.9% Medicaid, and 67.1% commercial.

Thesis: Turnaround. Our ML models identify $8.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -6.1% to 1.2% (+736bps).

Net Revenue HCRIS$110.4M
Current EBITDA COMPUTED$-6.8M
Operating Margin COMPUTED-6.1%
Occupancy HCRIS53.4%
Revenue / Bed COMPUTED$2.2M
Net-to-Gross HCRIS27.1%
Distress Probability ML45.4%

2. Market Context & Competitive Position

63
OR Hospitals
-8.1%
State Median Margin
25
Comparable Hospitals

OR has 63 Medicare-certified hospitals with a median operating margin of -8.1%. The target's margin of -6.1% places it above the state median. Among 25 size-comparable peers (25-100 beds), the median margin is -7.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (25-100), prioritizing same-state peers. 25 hospitals in the comp set.

HospitalStateBedsRevenueMargin
WILLAMETTE VALLEY MEDICAL CENT (Target)OR50$110.4M-6.1%
SKY LAKES MEDICAL CENTEROR90$251.4M-20.9%
PROVIDENCE MEDFORD MEDICAL CENOR96$239.8M-17.3%
SAMARITAN ALBANY GENERAL HOSPIOR67$220.1M-12.0%
LEGACY MOUNT HOOD MEDICAL CENTOR99$197.2M-10.2%
GOOD SHEPHERD MEDICAL CENTEROR25$177.5M5.3%
COLUMBIA MEMORIAL HOSPITALOR25$165.9M5.2%
SAMARITAN LEBANON COMM HOSPITAOR25$157.9M3.9%
PROVIDENCE NEWBERG MEDICAL CENOR40$151.5M10.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.3M+210bp18mo
Cost to Collect4.5%2.5%$2.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.3M+122bp9mo
Clean Claim Rate88.0%96.0%$71K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.3M
Cost to Collect
$2.2M
Denial Rate Reduction
$2.2M
A/R Days Reduction
$1.3M
Clean Claim Rate
$71K
Total EBITDA Uplift$8.1M
Current EBITDA$-6.8M
+ RCM Uplift+$8.1M
Pro Forma EBITDA$1.4M
Current Margin-6.1%
Pro Forma Margin1.2%
WC Released (1x)$4.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-10.4M$36.8M0.00x-100.0%
Base (11x exit)10.0x11.0x$-10.4M$37.1M0.00x-100.0%
Bull Case9.0x11.0x$-9.3M$60.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-9.3M$63.3M0.00x-100.0%
Bear Case11.0x10.0x$-11.4M$-514K0.00x-100.0%
Bear (11x exit)11.0x11.0x$-11.4M$-4.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 25 hospitals with 25-100 beds
  • Same-state prioritization (n=26)
  • Comp margins: P25=-16.1% / P50=-7.4% / P75=3.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.